MedTrace Logo

Syndrome Patterns for Chronic Atrophic Gastritis Malignant Transformation

NCT03314038 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-02-01

No results posted yet for this study

Summary

Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to explore Traditional Chinese Medicine (TCM) syndrome features in different stages of CAG malignant transformation respectively. The proposed study is a cross-sectional study based participant survey conducted in 4 hospitals in Beijing, China. After obtaining informed consent, a total of 2000 study patients will be recruited on-site in hospitals.

Conditions

  • TCM Syndrome of Chronic Atrophic Gastritis

Sponsors & Collaborators

  • The University of Science and Technology of China

    collaborator OTHER

  • China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Beijing University of Chinese Medicine

    lead OTHER

Principal Investigators

  • Xia Ding, MD · Beijing University of Chinese Medicine

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03314038 on ClinicalTrials.gov